3.49
price up icon6.08%   0.20
after-market 시간 외 거래: 3.56 0.07 +2.01%
loading

Cabaletta Bio Inc 주식(CABA)의 최신 뉴스

pulisher
Feb 24, 2026

Here’s why Jacob Funds established a position in Cabaletta Bio (CABA) - MSN

Feb 24, 2026
pulisher
Feb 24, 2026

Millennium Management LLC's Strategic Acquisition of Cabaletta B - GuruFocus

Feb 24, 2026
pulisher
Feb 24, 2026

Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference - The Manila Times

Feb 24, 2026
pulisher
Feb 23, 2026

Short Covering: Will Cabaletta Bio Inc announce a stock split2025 Price Targets & Scalable Portfolio Growth Methods - baoquankhu1.vn

Feb 23, 2026
pulisher
Feb 23, 2026

Aug EndMonth: What drives SATLWs stock price2025 Market Sentiment & Stock Market Timing Techniques - baoquankhu1.vn

Feb 23, 2026
pulisher
Feb 23, 2026

Dividend Watch: Is PECO stock a falling knife or bargain buyRisk Management & Growth Oriented Trade Recommendations - baoquankhu1.vn

Feb 23, 2026
pulisher
Feb 19, 2026

Market Rankings: Is Cabaletta Bio Inc stock trending bullishJuly 2025 Analyst Calls & High Accuracy Swing Trade Signals - baoquankhu1.vn

Feb 19, 2026
pulisher
Feb 18, 2026

Millennium Group (CABA) jointly reports 5.3% holding of 5.13M shares - Stock Titan

Feb 18, 2026
pulisher
Feb 18, 2026

Aug Shorts: Does Cabaletta Bio Inc have strong EBITDA marginsJuly 2025 Update & Accurate Buy Signal Notifications - baoquankhu1.vn

Feb 18, 2026
pulisher
Feb 18, 2026

Here’s Why Jacob Funds Established a Position in Cabaletta Bio (CABA) - Insider Monkey

Feb 18, 2026
pulisher
Feb 15, 2026

What are Cabaletta Bio Inc.’s recent SEC filings showingPortfolio Update Summary & Daily Risk Controlled Trade Plans - mfd.ru

Feb 15, 2026
pulisher
Feb 13, 2026

Best Swing Trade Stocks Right Now • Updated Daily - Benzinga

Feb 13, 2026
pulisher
Feb 13, 2026

Pharma News: Why retail investors favor Cabaletta Bio Inc. stock2025 Historical Comparison & Fast Entry High Yield Tips - mfd.ru

Feb 13, 2026
pulisher
Feb 13, 2026

Cabaletta Bio Kicks Off Pivotal Myositis Trial, Touts Automated CAR-T Manufacturing Path to 2027 BLA - MarketBeat

Feb 13, 2026
pulisher
Feb 12, 2026

Is Anavex Life Sciences (AVXL) Stock Outpacing Its Medical Peers This Year? - Nasdaq

Feb 12, 2026
pulisher
Feb 11, 2026

Aug Drivers: Is Cabaletta Bio Inc stock a smart retirement pickJuly 2025 Recap & Fast Moving Market Watchlists - baoquankhu1.vn

Feb 11, 2026
pulisher
Feb 11, 2026

CABA News Today | Why did Cabaletta Bio stock go up today? - MarketBeat

Feb 11, 2026
pulisher
Feb 09, 2026

Cabaletta Bio Takes Spotlight at Guggenheim Summit as Autoimmune Bet Advances - MyChesCo

Feb 09, 2026
pulisher
Feb 06, 2026

Update Recap: Is Cabaletta Bio Inc stock overvalued or fairly priced2025 Macro Impact & AI Powered Market Entry Strategies - baoquankhu1.vn

Feb 06, 2026
pulisher
Feb 06, 2026

Trend Review: Is Cabaletta Bio Inc stock overvalued or fairly pricedJuly 2025 Technicals & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn

Feb 06, 2026
pulisher
Feb 06, 2026

Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - The Globe and Mail

Feb 06, 2026
pulisher
Feb 05, 2026

Cabaletta Bio to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026 - Quiver Quantitative

Feb 05, 2026
pulisher
Feb 05, 2026

Risk Off: What is Cabaletta Bio Incs P E ratio telling usJuly 2025 PostEarnings & Weekly High Return Stock Forecasts - baoquankhu1.vn

Feb 05, 2026
pulisher
Feb 03, 2026

Swing Trade: Can Cabaletta Bio Inc deliver consistent dividendsQuarterly Earnings Summary & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn

Feb 03, 2026
pulisher
Feb 01, 2026

US Market Wrap: Can Cabaletta Bio Inc disrupt its industryJuly 2025 Outlook & Reliable Entry Point Alerts - baoquankhu1.vn

Feb 01, 2026
pulisher
Jan 31, 2026

Highs Report: Will Tucows Inc outperform its industry peersMarket Activity Recap & Fast Moving Stock Trade Plans - baoquankhu1.vn

Jan 31, 2026
pulisher
Jan 30, 2026

What makes Cabaletta Bio, Inc. (CABA) a strong momentum stock: Buy now? - MSN

Jan 30, 2026
pulisher
Jan 30, 2026

What Makes Cabaletta Bio, Inc. (CABA) a Strong Momentum Stock: Buy Now? - Yahoo Finance

Jan 30, 2026
pulisher
Jan 28, 2026

Cabaletta Bio, Inc. (NASDAQ:CABA) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Jan 28, 2026
pulisher
Jan 27, 2026

Guggenheim reiterates Buy rating on Cabaletta Bio stock, citing commercial plan - Investing.com Nigeria

Jan 27, 2026
pulisher
Jan 27, 2026

Cabaletta Bio: Do You Buy With The Insiders? (NASDAQ:CABA) - Seeking Alpha

Jan 27, 2026
pulisher
Jan 27, 2026

Is Cabaletta Bio (CABA) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Jan 27, 2026
pulisher
Jan 27, 2026

Largest borrow rate increases among liquid names - TipRanks

Jan 27, 2026
pulisher
Jan 26, 2026

Assessing Cabaletta Bio (CABA) Valuation After Insider Buying And FDA Clearance For Automated CAR T Manufacturing - Yahoo Finance

Jan 26, 2026
pulisher
Jan 25, 2026

Stock Analysis: Does Cabaletta Bio Inc have pricing powerWeekly Trend Recap & Daily Growth Stock Investment Tips - baoquankhu1.vn

Jan 25, 2026
pulisher
Jan 25, 2026

Strategic Partnerships Propel Cabaletta Bio Forward - StocksToTrade

Jan 25, 2026
pulisher
Jan 25, 2026

Cabaletta Bio Unveils Strategic Plans Amid Price Target Revision - timothysykes.com

Jan 25, 2026
pulisher
Jan 24, 2026

Cabaletta Bio Aims High with Strategic Initiatives for 2026​ - StocksToTrade

Jan 24, 2026
pulisher
Jan 24, 2026

Steven Nichtberger Bought 3.3% More Shares In Cabaletta Bio - Sahm

Jan 24, 2026
pulisher
Jan 23, 2026

Returns Recap: Is Cabaletta Bio Inc stock trending bullishGap Down & Community Verified Trade Signals - baoquankhu1.vn

Jan 23, 2026
pulisher
Jan 23, 2026

Cabaletta Bio Unveils Strategic Plans Amid Financial Forecast Changes - StocksToTrade

Jan 23, 2026
pulisher
Jan 23, 2026

Cabaletta Bio Stock (CABA) Opinions on Insider Buying and Clinical Updates - Quiver Quantitative

Jan 23, 2026
pulisher
Jan 23, 2026

Cabaletta targets 2027 FDA filing as autoimmune CAR-T push accelerates - MSN

Jan 23, 2026
pulisher
Jan 23, 2026

Cabaletta Bio Advances Rese-cel Toward Pivotal Milestones, Expands Autoimmune Cell Therapy Pipeline - RTTNews

Jan 23, 2026
pulisher
Jan 23, 2026

Why Cabaletta Bio (CABA) Is Up 41.3% After FDA Clears Automated CAR T Manufacturing Platforms - Yahoo Finance

Jan 23, 2026
pulisher
Jan 23, 2026

Cabaletta Bio to Present Pioneering Clinical Data on Rese-cel at Major Scientific Conferences - MSN

Jan 23, 2026
pulisher
Jan 22, 2026

Cabaletta Bio Sees Unusually Large Options Volume (NASDAQ:CABA) - MarketBeat

Jan 22, 2026
pulisher
Jan 22, 2026

Cabaletta Bio (CABA) Shares Surge 11% After Insider Buying - GuruFocus

Jan 22, 2026
$103.24
price down icon 1.52%
$51.37
price up icon 1.68%
$28.66
price up icon 1.42%
$109.84
price down icon 0.94%
$148.61
price down icon 6.31%
biotechnology ONC
$352.23
price down icon 4.54%
자본화:     |  볼륨(24시간):